Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL
Friday, February 20, 2026Deciphera Pharmaceuticals a member of Ono Pharmaceutical Co Ltd Headquarters Osaka Japan President and COO Toichi Takino Ono today announced that the US Food and Drug Administration FDA has accepted
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
Thursday, February 19, 2026Johnson Johnson healthcares leading most comprehensive innovation powerhouse today announced a more than billion investment in a next generation cell therapy manufacturing facility in Montgomery County Pennsylvania
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
Thursday, February 19, 2026Sensei Biotherapeutics Inc today announced that it has acquired Faeth Therapeutics Inc Faeth a clinicalstage biotechnology company developing multinode therapies that target tumor metabolism and signaling
Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm
Thursday, February 19, 2026Tempus AI Inc a technology company leading the adoption of AI to advance precision medicine today announced the launch of its new HRDRNA algorithm This nextgeneration model represents a significant improvement
Cellares and University of Wisconsin School of Medicine and Public Health Expand Partnership to Clinical Manufacturing of CRISPR-Edited CAR-T for Solid Tumors
Thursday, February 19, 2026Cellares the first Integrated Development and Manufacturing Organization IDMO and the University of Wisconsin UW School of Medicine and Public Health today announced an expansion of their partnership to support
Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage
Thursday, February 19, 2026Waters Corporation today launched mm ID liquid chromatography LC columns with Waters MaxPeak Premier Technology for its ACQUITY BioResolve and GTxResolve Column brands
Pharmacelera raises €6M to expand in U.S. and build out its high speed, high accuracy, deep tech drug discovery platform
Wednesday, February 18, 2026Pharmacelera a deep tech company applying Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery has closed a million investment round to accelerate its expansion in the United States and grow the capabilities
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
Wednesday, February 18, 2026Twist Bioscience Corporation a midcap growth and value biotech company today announced that it has entered into a licensing agreement with Invenra Inc Invenra a company that has developed platform technologies
Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL
Wednesday, February 18, 2026Deciphera Pharmaceuticals a member of Ono Pharmaceutical Co Ltd Headquarters Osaka Japan President and COO Toichi Takino Ono today announced that the US Food and Drug Administration FDA
Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE
Wednesday, February 18, 2026Moderna Inc today announced that the European Commission EC has granted marketing authorization for mNEXSPIKE mRNA a new COVID vaccine for active immunization to prevent COVID caused by SARSCoV in individuals aged years and older
